[Fargo, ND] – FamGenix, an industry-leading provider of family health history, pedigree and genetic risk assessment solutions, announces its successful completion of a System and Organization Controls (SOC) 2 Type 1 examination. This milestone, established by the American Institute of Certified Public Accountants (AICPA), reflects the company’s rigorous dedication to maintaining high-level data security and privacy protocols for healthcare systems, clinical partners, and individual patients.
The independent audit was conducted by a reputable third-party CPA firm. The examination verified that FamGenix’s security controls are intentionally designed and robustly structured to safeguard sensitive medical and lineage information. This attestation directly supports the platform’s compliance with health regulations like HIPAA and GDPR.
“Trust and data privacy are foundational when managing family clinical histories and genetic records,” said Michael Brammer, Founder and CEO of FamGenix. “Completing our SOC 2 Type 1 review gives our enterprise healthcare partners and clinicians absolute assurance that security governance is built natively into our architecture as we expand our genetic risk technologies.”
By securing a SOC 2 Type 1 report, FamGenix streamlines vendor onboarding for health systems and clinical pipelines. The standardized report satisfies complex institutional security questionnaires, validating that the platform protects digital assets before expanding toward a multi-month SOC 2 Type 2 longitudinal evaluation, expected to be completed by September 1st, 2026.
About FamGenix
FamGenix publishes pedigree software tools for healthcare systems worldwide to accurately gather family health histories from patients to assess their risk of hereditary disease. Founded by data experts with over 100 years of combined experience in pedigree drawing and risk assessment technology, the FamGenix suite of products empowers clinical workflows to securely track hereditary disease risk markers long before a patient experiences a medical crisis.